Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048637499> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W3048637499 endingPage "795" @default.
- W3048637499 startingPage "789" @default.
- W3048637499 abstract "Abstract A simple, precise, rapid and accurate reversed-phase high-performance liquid chromatography (RP-HPLC) method was developed and validated for analysis of safinamide mesylate (SAF) in presence of its basic degradate, and co-administered drugs levodopa and ondansetron. The mobile phase consisted of acetonitrile and 20 mM potassium dihyrogen orthophosphate buffer having pH = 5 (40: 60 v/v). Quantification was achieved with ultraviolet detector at 226 nm. The linear range was 0.5–10 μg/mL with mean recovery ± SD of 99.72 ± 1.59. The peak purity of SAF in pharmaceutical preparation spiked with its degradate and co-administered drugs revealed symmetry factor (999.8) within the calculated threshold (>998.1). The suggested method was validated in compliance with the International Conference on Harmonization (ICH) guidelines and statistically compared with the manufacturer HPLC method with no significant difference in terms of accuracy and precision. The assay method was successfully used to estimate SAF in tablets with good percentage recoveries. The high sensitivity (lower than Cmax of the drug 0.65 μg/mL) of the proposed HPLC method enabled the determination of SAF in presence of its basic degradate and co-administered drug, ondansetron in human plasma with acceptable accuracy. The suggested HPLC method could be used in Quality Control (QC) lab for analysis of the studied drug in pharmaceutical preparation." @default.
- W3048637499 created "2020-08-18" @default.
- W3048637499 creator A5011893158 @default.
- W3048637499 creator A5056782824 @default.
- W3048637499 creator A5079413940 @default.
- W3048637499 creator A5082154679 @default.
- W3048637499 date "2020-08-10" @default.
- W3048637499 modified "2023-09-24" @default.
- W3048637499 title "New and validated RP-HPLC Method for Quantification of Safinamide Mesylate in Presence of Its Basic Degradate, Levodopa and Ondansetron: Application to Human Plasma" @default.
- W3048637499 cites W2010157432 @default.
- W3048637499 cites W2072901404 @default.
- W3048637499 cites W2111425424 @default.
- W3048637499 cites W2269822211 @default.
- W3048637499 cites W2585273885 @default.
- W3048637499 doi "https://doi.org/10.1093/chromsci/bmaa043" @default.
- W3048637499 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32776090" @default.
- W3048637499 hasPublicationYear "2020" @default.
- W3048637499 type Work @default.
- W3048637499 sameAs 3048637499 @default.
- W3048637499 citedByCount "4" @default.
- W3048637499 countsByYear W30486374992022 @default.
- W3048637499 countsByYear W30486374992023 @default.
- W3048637499 crossrefType "journal-article" @default.
- W3048637499 hasAuthorship W3048637499A5011893158 @default.
- W3048637499 hasAuthorship W3048637499A5056782824 @default.
- W3048637499 hasAuthorship W3048637499A5079413940 @default.
- W3048637499 hasAuthorship W3048637499A5082154679 @default.
- W3048637499 hasConcept C141071460 @default.
- W3048637499 hasConcept C178790620 @default.
- W3048637499 hasConcept C179998833 @default.
- W3048637499 hasConcept C181389837 @default.
- W3048637499 hasConcept C185592680 @default.
- W3048637499 hasConcept C22979827 @default.
- W3048637499 hasConcept C2777170512 @default.
- W3048637499 hasConcept C2780194963 @default.
- W3048637499 hasConcept C2780580376 @default.
- W3048637499 hasConcept C43617362 @default.
- W3048637499 hasConcept C4725764 @default.
- W3048637499 hasConcept C71924100 @default.
- W3048637499 hasConcept C98274493 @default.
- W3048637499 hasConceptScore W3048637499C141071460 @default.
- W3048637499 hasConceptScore W3048637499C178790620 @default.
- W3048637499 hasConceptScore W3048637499C179998833 @default.
- W3048637499 hasConceptScore W3048637499C181389837 @default.
- W3048637499 hasConceptScore W3048637499C185592680 @default.
- W3048637499 hasConceptScore W3048637499C22979827 @default.
- W3048637499 hasConceptScore W3048637499C2777170512 @default.
- W3048637499 hasConceptScore W3048637499C2780194963 @default.
- W3048637499 hasConceptScore W3048637499C2780580376 @default.
- W3048637499 hasConceptScore W3048637499C43617362 @default.
- W3048637499 hasConceptScore W3048637499C4725764 @default.
- W3048637499 hasConceptScore W3048637499C71924100 @default.
- W3048637499 hasConceptScore W3048637499C98274493 @default.
- W3048637499 hasIssue "9" @default.
- W3048637499 hasLocation W30486374991 @default.
- W3048637499 hasOpenAccess W3048637499 @default.
- W3048637499 hasPrimaryLocation W30486374991 @default.
- W3048637499 hasRelatedWork W1588095382 @default.
- W3048637499 hasRelatedWork W2016713066 @default.
- W3048637499 hasRelatedWork W2018671480 @default.
- W3048637499 hasRelatedWork W2063013405 @default.
- W3048637499 hasRelatedWork W2063953969 @default.
- W3048637499 hasRelatedWork W2075525679 @default.
- W3048637499 hasRelatedWork W2369983184 @default.
- W3048637499 hasRelatedWork W2376531500 @default.
- W3048637499 hasRelatedWork W2387434678 @default.
- W3048637499 hasRelatedWork W3048637499 @default.
- W3048637499 hasVolume "58" @default.
- W3048637499 isParatext "false" @default.
- W3048637499 isRetracted "false" @default.
- W3048637499 magId "3048637499" @default.
- W3048637499 workType "article" @default.